Company: SNWV
Filing Date: 2025-08-07
Form Type: 10-Q
Source: 0001628280-25-038937
Chunk: 88

Company: SANUWAVE Health, Inc.
Filing Date: 2025-08-07
Form: 10-Q
Item: Part I, Item 8
Chunk 88
---
.00Expected volatility62%62%Risk-free interest rate4%4%Expected holding period, in years4.875.12Dividend yield0%0%

14.       Net Income (Loss) per Share

Basic net income (loss) per share is computed based on the weighted average number of shares outstanding during the applicable period, including nominally priced warrants. Diluted net income (loss) per share is computed by dividing the net income (loss) attributable to common stockholders by the weighted average number of shares of common stock and dilutive common stock equivalents outstanding. Diluted net income (loss) per share is calculated based on the weighted average of shares of common stock outstanding and the number of additional shares that would have been outstanding if the potentially dilutive securities had been issued. The Company uses the treasury stock method to calculate the number of shares for the nominally priced warrants.

20

Three Months Ended June 30,Six Months Ended June 30,(in thousands, except per share data)2025202420252024Numerator:Basic net income (loss) available to stockholders1,055 6,561 (4,621)2,033 Change in fair value of warrants(990)- - - Diluted net income (loss) available to stockholders65 6,561 (4,621)2,033 Denominator:Weighted average common shares outstanding - Basic8,562 3,153 8,555 3,126 Dilutive effect of warrants363 - - - Dilutive effect of stock options243 - - - Dilutive effect of convertible promissory notes including interest- 547 - 538 Weighted average common shares outstanding - Diluted9,168 3,700 8,555 3,664 Net income (loss) per share:Basic$0.12 $2.08 $(0.54)$0.65 Diluted$0.01 $1.77 $(0.54)$0.55 Diluted net income (loss) per share is computed by dividing the net loss attributable to common stockholders by the weighted average number of shares of common stock and dilutive common stock equivalents outstanding that are nominally priced. In June 2024, the Company did not have any dilutive common stock equivalents that were nominally priced. The following securities were excluded from the calculation of diluted